| R-HSA-109581 | Apoptosis | IEA |
| R-HSA-1168372 | Downstream signaling events of B Cell Receptor (BCR) | TAS |
| R-HSA-1169091 | Activation of NF-kappaB in B cells | TAS |
| R-HSA-1234174 | Regulation of Hypoxia-inducible Factor (HIF) by oxygen | TAS |
| R-HSA-1234176 | Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | TAS |
| R-HSA-1236974 | ER-Phagosome pathway | IEA |
| R-HSA-1236975 | Antigen processing-Cross presentation | TAS |
| R-HSA-1236975 | Antigen processing-Cross presentation | IEA |
| R-HSA-1236978 | Cross-presentation of soluble exogenous antigens (endosomes) | TAS |
| R-HSA-1257604 | PIP3 activates AKT signaling | TAS |
| R-HSA-1266738 | Developmental Biology | IEA |
| R-HSA-1280215 | Cytokine Signaling in Immune system | TAS |
| R-HSA-1280218 | Adaptive Immune System | TAS |
| R-HSA-1280218 | Adaptive Immune System | IEA |
| R-HSA-1430728 | Metabolism | TAS |
| R-HSA-162582 | Signal Transduction | TAS |
| R-HSA-162582 | Signal Transduction | IEA |
| R-HSA-162906 | HIV Infection | TAS |
| R-HSA-162909 | Host Interactions of HIV factors | TAS |
| R-HSA-1640170 | Cell Cycle | TAS |
| R-HSA-1643685 | Disease | TAS |
| R-HSA-168249 | Innate Immune System | TAS |
| R-HSA-168256 | Immune System | TAS |
| R-HSA-168256 | Immune System | IEA |
| R-HSA-169911 | Regulation of Apoptosis | IEA |
| R-HSA-174084 | Autodegradation of Cdh1 by Cdh1:APC/C | TAS |
| R-HSA-174113 | SCF-beta-TrCP mediated degradation of Emi1 | TAS |
| R-HSA-174143 | APC/C-mediated degradation of cell cycle proteins | TAS |
| R-HSA-174154 | APC/C:Cdc20 mediated degradation of Securin | TAS |
| R-HSA-174178 | APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | TAS |
| R-HSA-174184 | Cdc20:Phospho-APC/C mediated degradation of Cyclin A | TAS |
| R-HSA-176408 | Regulation of APC/C activators between G1/S and early anaphase | TAS |
| R-HSA-176409 | APC/C:Cdc20 mediated degradation of mitotic proteins | TAS |
| R-HSA-176814 | Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | TAS |
| R-HSA-179419 | APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | TAS |
| R-HSA-180534 | Vpu mediated degradation of CD4 | TAS |
| R-HSA-180585 | Vif-mediated degradation of APOBEC3G | TAS |
| R-HSA-187577 | SCF(Skp2)-mediated degradation of p27/p21 | TAS |
| R-HSA-195253 | Degradation of beta-catenin by the destruction complex | TAS |
| R-HSA-195721 | Signaling by WNT | TAS |
| R-HSA-201681 | TCF dependent signaling in response to WNT | TAS |
| R-HSA-202403 | TCR signaling | TAS |
| R-HSA-202424 | Downstream TCR signaling | TAS |
| R-HSA-211733 | Regulation of activated PAK-2p34 by proteasome mediated degradation | IEA |
| R-HSA-212436 | Generic Transcription Pathway | IEA |
| R-HSA-212436 | Generic Transcription Pathway | TAS |
| R-HSA-2262749 | Cellular response to hypoxia | TAS |
| R-HSA-2262752 | Cellular responses to stress | TAS |
| R-HSA-2454202 | Fc epsilon receptor (FCERI) signaling | TAS |
| R-HSA-2467813 | Separation of Sister Chromatids | TAS |
| R-HSA-2555396 | Mitotic Metaphase and Anaphase | TAS |
| R-HSA-2871837 | FCERI mediated NF-kB activation | TAS |
| R-HSA-349425 | Autodegradation of the E3 ubiquitin ligase COP1 | TAS |
| R-HSA-350562 | Regulation of ornithine decarboxylase (ODC) | TAS |
| R-HSA-351202 | Metabolism of polyamines | TAS |
| R-HSA-376176 | Signaling by ROBO receptors | IEA |
| R-HSA-382551 | Transport of small molecules | TAS |
| R-HSA-382556 | ABC-family proteins mediated transport | TAS |
| R-HSA-3858494 | Beta-catenin independent WNT signaling | TAS |
| R-HSA-392499 | Metabolism of proteins | TAS |
| R-HSA-4086400 | PCP/CE pathway | TAS |
| R-HSA-422475 | Axon guidance | IEA |
| R-HSA-446652 | Interleukin-1 family signaling | TAS |
| R-HSA-449147 | Signaling by Interleukins | TAS |
| R-HSA-450408 | AUF1 (hnRNP D0) binds and destabilizes mRNA | TAS |
| R-HSA-450531 | Regulation of mRNA stability by proteins that bind AU-rich elements | TAS |
| R-HSA-453274 | Mitotic G2-G2/M phases | TAS |
| R-HSA-453276 | Regulation of mitotic cell cycle | TAS |
| R-HSA-453279 | Mitotic G1-G1/S phases | TAS |
| R-HSA-4608870 | Asymmetric localization of PCP proteins | TAS |
| R-HSA-4641257 | Degradation of AXIN | TAS |
| R-HSA-4641258 | Degradation of DVL | TAS |
| R-HSA-5357801 | Programmed Cell Death | IEA |
| R-HSA-5358346 | Hedgehog ligand biogenesis | TAS |
| R-HSA-5358351 | Signaling by Hedgehog | TAS |
| R-HSA-5358351 | Signaling by Hedgehog | IEA |
| R-HSA-5362768 | Hh mutants that don't undergo autocatalytic processing are degraded by ERAD | TAS |
| R-HSA-5387390 | Hh mutants abrogate ligand secretion | TAS |
| R-HSA-5607761 | Dectin-1 mediated noncanonical NF-kB signaling | TAS |
| R-HSA-5607764 | CLEC7A (Dectin-1) signaling | TAS |
| R-HSA-5610780 | Degradation of GLI1 by the proteasome | TAS |
| R-HSA-5610783 | Degradation of GLI2 by the proteasome | IEA |
| R-HSA-5610785 | GLI3 is processed to GLI3R by the proteasome | TAS |
| R-HSA-5610787 | Hedgehog 'off' state | IEA |
| R-HSA-5610787 | Hedgehog 'off' state | TAS |
| R-HSA-5619084 | ABC transporter disorders | TAS |
| R-HSA-5619115 | Disorders of transmembrane transporters | TAS |
| R-HSA-5621481 | C-type lectin receptors (CLRs) | TAS |
| R-HSA-5632684 | Hedgehog 'on' state | TAS |
| R-HSA-5658442 | Regulation of RAS by GAPs | TAS |
| R-HSA-5663202 | Diseases of signal transduction | TAS |
| R-HSA-5663205 | Infectious disease | TAS |
| R-HSA-5668541 | TNFR2 non-canonical NF-kB pathway | TAS |
| R-HSA-5673001 | RAF/MAP kinase cascade | TAS |
| R-HSA-5676590 | NIK-->noncanonical NF-kB signaling | TAS |
| R-HSA-5678895 | Defective CFTR causes cystic fibrosis | TAS |
| R-HSA-5683057 | MAPK family signaling cascades | TAS |
| R-HSA-5684996 | MAPK1/MAPK3 signaling | TAS |
| R-HSA-5687128 | MAPK6/MAPK4 signaling | TAS |
| R-HSA-5688426 | Deubiquitination | TAS |
| R-HSA-5689603 | UCH proteinases | TAS |
| R-HSA-5689880 | Ub-specific processing proteases | TAS |
| R-HSA-597592 | Post-translational protein modification | TAS |
| R-HSA-6807070 | PTEN Regulation | TAS |
| R-HSA-68827 | CDT1 association with the CDC6:ORC:origin complex | TAS |
| R-HSA-68867 | Assembly of the pre-replicative complex | TAS |
| R-HSA-68874 | M/G1 Transition | TAS |
| R-HSA-68882 | Mitotic Anaphase | TAS |
| R-HSA-68886 | M Phase | TAS |
| R-HSA-68949 | Orc1 removal from chromatin | TAS |
| R-HSA-69002 | DNA Replication Pre-Initiation | TAS |
| R-HSA-69017 | CDK-mediated phosphorylation and removal of Cdc6 | TAS |
| R-HSA-69052 | Switching of origins to a post-replicative state | TAS |
| R-HSA-69202 | Cyclin E associated events during G1/S transition | TAS |
| R-HSA-69206 | G1/S Transition | TAS |
| R-HSA-69229 | Ubiquitin-dependent degradation of Cyclin D1 | TAS |
| R-HSA-69239 | Synthesis of DNA | TAS |
| R-HSA-69242 | S Phase | TAS |
| R-HSA-69275 | G2/M Transition | TAS |
| R-HSA-69278 | Cell Cycle, Mitotic | TAS |
| R-HSA-69306 | DNA Replication | TAS |
| R-HSA-69481 | G2/M Checkpoints | TAS |
| R-HSA-69541 | Stabilization of p53 | TAS |
| R-HSA-69563 | p53-Dependent G1 DNA Damage Response | TAS |
| R-HSA-69580 | p53-Dependent G1/S DNA damage checkpoint | TAS |
| R-HSA-69601 | Ubiquitin Mediated Degradation of Phosphorylated Cdc25A | TAS |
| R-HSA-69610 | p53-Independent DNA Damage Response | TAS |
| R-HSA-69613 | p53-Independent G1/S DNA damage checkpoint | TAS |
| R-HSA-69615 | G1/S DNA Damage Checkpoints | TAS |
| R-HSA-69620 | Cell Cycle Checkpoints | TAS |
| R-HSA-69656 | Cyclin A:Cdk2-associated events at S phase entry | TAS |
| R-HSA-71291 | Metabolism of amino acids and derivatives | TAS |
| R-HSA-73857 | RNA Polymerase II Transcription | IEA |
| R-HSA-73857 | RNA Polymerase II Transcription | TAS |
| R-HSA-74160 | Gene expression (Transcription) | IEA |
| R-HSA-74160 | Gene expression (Transcription) | TAS |
| R-HSA-75815 | Ubiquitin-dependent degradation of Cyclin D | TAS |
| R-HSA-8852276 | The role of GTSE1 in G2/M progression after G2 checkpoint | TAS |
| R-HSA-8854050 | FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | TAS |
| R-HSA-8878159 | Transcriptional regulation by RUNX3 | TAS |
| R-HSA-8878166 | Transcriptional regulation by RUNX2 | IEA |
| R-HSA-8878166 | Transcriptional regulation by RUNX2 | TAS |
| R-HSA-8878171 | Transcriptional regulation by RUNX1 | TAS |
| R-HSA-8939236 | RUNX1 regulates transcription of genes involved in differentiation of HSCs | TAS |
| R-HSA-8939902 | Regulation of RUNX2 expression and activity | IEA |
| R-HSA-8939902 | Regulation of RUNX2 expression and activity | TAS |
| R-HSA-8941858 | Regulation of RUNX3 expression and activity | TAS |
| R-HSA-8948751 | Regulation of PTEN stability and activity | TAS |
| R-HSA-8951664 | Neddylation | TAS |
| R-HSA-8953854 | Metabolism of RNA | TAS |
| R-HSA-8953897 | Cellular responses to external stimuli | TAS |
| R-HSA-9006925 | Intracellular signaling by second messengers | TAS |
| R-HSA-9010553 | Regulation of expression of SLITs and ROBOs | IEA |
| R-HSA-9020702 | Interleukin-1 signaling | TAS |
| R-HSA-983168 | Antigen processing: Ubiquitination & Proteasome degradation | TAS |
| R-HSA-983169 | Class I MHC mediated antigen processing & presentation | TAS |
| R-HSA-983169 | Class I MHC mediated antigen processing & presentation | IEA |
| R-HSA-983705 | Signaling by the B Cell Receptor (BCR) | TAS |